Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Medapp S.A. | WQ1 | 13. mar 2025 | 0.03 | -0.58 |
Medaro Mining | 1ZY0 | 13. mar 2025 | 0.05 | 0.00 |
MEDBRIGHT AI INVTS INC. | Y30 | 13. mar 2025 | 0.03 | +1.79 |
MedCap | 61MA | 13. mar 2025 | 32.90 | +0.46 |
Medesis Pharma S.A. | 76D | 13. mar 2025 | 0.29 | 0.00 |
Medexus Pharmaceuticals Inc | P731 | 13. mar 2025 | 1.60 | 0.00 |
Media and Games Invest SE | M8G | 13. mar 2025 | 3.45 | -0.14 |
Mediaco Holding Inc. - Class A | 3WX | 13. mar 2025 | 0.98 | +1.03 |
MEDIAN POLSKA S.A. ZY-,10 | GY3 | 13. mar 2025 | 0.16 | -0.63 |
Median Technologies | 4ZG | 13. mar 2025 | 2.65 | -0.19 |
Medibank Private Limited | MPV | 13. mar 2025 | 2.46 | +1.65 |
Medical Facilities Corp | 31F | 13. mar 2025 | 10.40 | -2.80 |
Medical Properties Trust Inc | M3P | 13. mar 2025 | 5.43 | -1.06 |
Mediclin AG | MED | 13. mar 2025 | 2.88 | 0.00 |
Medicover B | 5M0B | 13. mar 2025 | 17.58 | -2.66 |
Medicure Inc | NGQ1 | 13. mar 2025 | 0.40 | 0.00 |
MEDICUS PHARMA LTD. | N460 | 13. mar 2025 | 2.70 | +15.38 |
MEDIFAST INC | MDF | 13. mar 2025 | 12.15 | -1.22 |
Medigene AG | MDG1 | 13. mar 2025 | 1.46 | -5.55 |
Medimi | 79T | 13. mar 2025 | 0.00 | 0.00 |
Medincell S.A. | MEB | 13. mar 2025 | 13.48 | -0.74 |
MEDIOBANCA S.P.A.UNSP.ADR | ME90 | 13. mar 2025 | 16.80 | +1.82 |
Mediobanca SpA | ME9 | 13. mar 2025 | 16.91 | +1.38 |
Medios AG | ILM1 | 13. mar 2025 | 12.38 | -1.59 |
Medipal Holdings Corporation | 59Z | 13. mar 2025 | 13.90 | 0.00 |
Medipharm Labs Corp | MLZ | 13. mar 2025 | 0.04 | -4.27 |
Medistim | MD1 | 13. mar 2025 | 15.80 | 0.00 |
MEDIVIR AB | MVR0 | 13. mar 2025 | 0.12 | +23.95 |
MediWound Ltd. - Ordinary Shares | M8W | 13. mar 2025 | 16.20 | +3.85 |
Medley Inc. | 3YV | 13. mar 2025 | 18.70 | -2.09 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.